New advance in COPD maintenance treatment, Spiolto ® Respimat®, approved in first European countries
New advance in COPD maintenance treatment, Spiolto ® Respimat®, approved in first European countries
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news
More News: Chronic Obstructive Pulmonary | Research